South Korea's Ubix Therapeutics, Inc., a pioneer in Targeted Protein Degradation (TPD) technology, has successfully raised $19.5M in a Pre-IPO round led by both new and existing investors, including Solidus Investment, Atinum Investment, and QUAD Investment Management. The funding aims to fuel clinical trials, expand their drug pipeline, and accelerate IPO preparations, showcasing significant global potential in refractory cancer treatments. WOW Partners(와우파트너스) https://lnkd.in/em3uTrNd #lifesciences
About us
We cover everything important across Life Sciences. Whether you're interested in the newest Fundraise, latest Trends, most innovative Companies, or the People that drive our industry, we make sure you stay up to date on it all.
- Website
-
https://www.surveymonkey.com/r/Q29HSMJ
External link for Life Sciences VCLink
- Industry
- Internet News
- Company size
- 1 employee
Updates
-
Berlin-based DeepTech startup Apheris has successfully raised €20.1 million in a Series A round led by OTB Ventures and eCAPITAL, enabling the company to advance AI-driven innovation in life sciences data collaboration. With a federated computing approach and a growing network of biopharmaceutical clients, Apheris is revolutionizing data-sharing while safeguarding privacy and intellectual property with its cutting-edge technology. David Cendón Garcia | EU-Startups https://lnkd.in/d_DA_jPC #lifesciences
DeepTech Apheris secures €20.1 million to transform life sciences data collaboration | EU-Startups
https://www.eu-startups.com
-
AusperBio has raised $73 million in a Series B funding round led by Hankang Capital, joined by Sherpa Capital, CDH Investments, Qiming Venture Partners, InnoPinnacle Fund, and YuanBio Venture Capital. This financing will support the clinical development of AHB-137 and expand its therapeutic pipeline, aiming for a functional cure for chronic hepatitis B. Amit Chowdhry | Pulse 2.0 https://lnkd.in/e39RaRus #lifesciences
AusperBio: $73 Million (Series B) Raised To Advance Targeted Oligonucleotide Therapies
https://pulse2.com
-
NeuroKaire (formerly Genetika+) has raised $10M in funding to further scale its operations and expand pharmaceutical partnerships. The precision medicine company, led by CEO and Founder Talia Cohen Solal, aims to revolutionize treatment options for psychiatric and neurological diseases using advanced neuronal readout technology. GreyBird Ventures, LLC led the round with participation from Meron Capital and Jumpspeed Ventures. citybiz https://lnkd.in/edXkgCqX #lifesciences
NeuroKaire Raises $10M
https://www.citybiz.co
-
Novo Holdings leads the $100M Series C funding round for SiteOne Therapeutics, Inc., a California-based biotech focused on developing non-opioid therapeutics targeting sensory hyperexcitability disorders. SiteOne plans to advance selective ion channel modulators through clinical proof-of-concept studies, with CEO John Mulcahy, Ph.D., Ph.D., emphasizing their strategy to own the action potential in the peripheral nervous system. Gabrielle Masson | Fierce Biotech https://lnkd.in/ep6-ZbXT #lifesciences
Novo Holdings leads SiteOne's $100M series C for non-opioid pain treatments
fiercebiotech.com
-
Biotech startup Nintx has raised $10 million in a Series A funding round led by venture capital firms, including Pitanga, ECOA Capital, and MOV Investimentos, to advance groundbreaking therapies for multifactorial diseases. The company is leveraging Brazil’s biodiversity with its innovative technologies and aims to license its first drug candidate within three years to major pharma companies. Pie Kamau Kanali | Startup-Weekly, The Early Stage Startup Interview Database https://lnkd.in/e7ki6cSr #lifesciences
Biotech startup Nintx raises $10m to advance new generation of medicines based on Brazilian biodiversity
startup-weekly.com
-
Irish medtech spin-out LaNua Medical has secured €6m in seed funding to advance its innovative embolisation device 'Ecore,' which aims to modernize procedures, improve safety, and enable new clinical applications. The round was co-led by Elkstone and Atlantic Bridge, with support from Enterprise Ireland and Furthr VC. LaNua Medical is also expanding into the US to gain regulatory approval. Ciarán Mather | Silicon Republic https://lnkd.in/gbEP_H8G #lifesciences
UCD medtech spin-out LaNua Medical nabs €6m in funding
https://www.siliconrepublic.com
-
Edinburgh-based Concinnity Genetics has secured £3 million in Seed funding to advance its AI-driven RNA-based gene therapy safety systems. The funding round was led by Eos Advisory, with participation from Scottish Enterprise, Old College Capital, and Maven Capital Partners. Andrew McNeill of Eos Advisory highlighted the transformative potential of Concinnity's technology, which is seen as a 'holy grail' for gene therapies. Cate Lawrence | Tech.eu https://lnkd.in/efSWPuRM #lifesciences
Tech.eu - European Startup, Funding and Technology News
tech.eu
-
BioSapien, a USA- and UAE-based biotech startup, has secured $5.5 million in a pre-Series A funding round led by Global Ventures, with participation from Dara Holdings. The funds will be used to accelerate the development of MediChip, a 3D-printed implant designed to transform cancer treatment by delivering drugs directly to tumors. Noor Sweid of Global Ventures and Khatija A., CEO of BioSapien, highlight the innovative potential of this breakthrough. WAYA https://lnkd.in/ehqShBiz #lifesciences
BioSapien Secures USD 5.5M to Transform Cancer Treatment in the UAE - WAYA
https://waya.media
-
Lyfegen, a Basel-based drug rebate management technology company, has raised an additional CHF5M in its Series A funding round. The round was led by TX Ventures, with participation from aMoon Fund and other investors. FinSMEs https://lnkd.in/eAaXw6Am #lifesciences
Lyfegen Raises Additional CHF5M in Series A Funding
https://www.finsmes.com